医学
消胆胺
血浆置换术
肝病
慢性肝病
疾病
重症监护医学
皮肤病科
胃肠病学
内科学
免疫学
肝硬化
胆固醇
抗体
作者
Ranya Selim,Joseph Ahn
标识
DOI:10.1016/j.cld.2022.08.011
摘要
Pruritus can be associated with chronic liver disease, particularly cholestatic liver disease. Although the pathophysiology is uncertain, there are a few proposed mechanisms and much is still being discovered. Workup involves an assessment to rule out a dermatologic, neurologic, psychogenic, or other underlying systemic disorder. First-line therapy is cholestyramine, which is generally well tolerated and effective. In those who fail cholestyramine, alternative drugs including rifampicin and μ-opioid receptor antagonists can be considered. If medical therapy is ineffective and pruritus is significant, alternative experimental therapies such as albumin dialysis, photopheresis, plasmapheresis, and biliary diversion can be considered.
科研通智能强力驱动
Strongly Powered by AbleSci AI